Search Results Search Sort by RelevanceMost Recent Medicine and Society Apr 2022 Language and Health (In)Equity in US Latinx Communities Zackary Berger, MD, PhD and Yael Peled, DPhil In US health care, language and linguistic difference are often conceived in discrete, instrumental, and monolithic terms. AMA J Ethics. 2022;24(4):E313-318. doi: 10.1001/amajethics.2022.313. Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133. Medical Education Feb 2022 ¿Qué deben saber los médicos que atienden a policías sobre el daño moral? Daniel M. Blumberg, PhD AMA J Ethics. 2022;E126-132. doi: 10.1001/amajethics.2022.126. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Medical Education May 2022 Is My Patient Taking an Unsafe Dietary Supplement? Ilisa B. G. Bernstein, PharmD, JD and Karin L. Bolte, JD Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe. AMA J Ethics. 2022;24(5):E390-395. doi: 10.1001/amajethics.2022.390. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Medicine and Society Apr 2022 Language and Health (In)Equity in US Latinx Communities Zackary Berger, MD, PhD and Yael Peled, DPhil In US health care, language and linguistic difference are often conceived in discrete, instrumental, and monolithic terms. AMA J Ethics. 2022;24(4):E313-318. doi: 10.1001/amajethics.2022.313.
Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133.
Medical Education Feb 2022 ¿Qué deben saber los médicos que atienden a policías sobre el daño moral? Daniel M. Blumberg, PhD AMA J Ethics. 2022;E126-132. doi: 10.1001/amajethics.2022.126.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Medical Education May 2022 Is My Patient Taking an Unsafe Dietary Supplement? Ilisa B. G. Bernstein, PharmD, JD and Karin L. Bolte, JD Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe. AMA J Ethics. 2022;24(5):E390-395. doi: 10.1001/amajethics.2022.390.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.